Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Artivion Inc AORT

Healthcare Medical Devices
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment... see more

Recent & Breaking News (NYSE:AORT)

Artivion Reports Third Quarter 2024 Financial Results

PR Newswire November 7, 2024

Artivion to Participate in Upcoming Investor Conferences

PR Newswire November 5, 2024

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results

PR Newswire October 24, 2024

Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting

PR Newswire October 10, 2024

Artivion Reports Second Quarter 2024 Financial Results

PR Newswire August 8, 2024

Artivion to Participate in Upcoming Investor Conferences

PR Newswire August 5, 2024

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results

PR Newswire July 25, 2024

Artivion Amends Agreements with Endospan

PR Newswire July 1, 2024

Artivion Reports First Quarter 2024 Financial Results

PR Newswire May 6, 2024

Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting

PR Newswire April 29, 2024

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results

PR Newswire April 22, 2024

Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference

PR Newswire April 1, 2024

Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

PR Newswire March 6, 2024

Artivion Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire February 15, 2024

Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results

PR Newswire February 1, 2024

Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting

PR Newswire January 29, 2024

Artivion Obtains $350 Million in Senior Secured Credit Facilities

PR Newswire January 18, 2024

Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer

PR Newswire December 6, 2023

Artivion Announces Completion of Enrollment in PERSEVERE Trial

PR Newswire November 9, 2023

Artivion to Participate in Upcoming Investor Conferences

PR Newswire November 8, 2023